ANTHONY VISCON: Open Payments
NPI 1447809884 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $157 |
| GlaxoSmithKline, LLC. | 1 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Novo Nordisk Inc | 3 | $55 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
Products named: BENLYSTA, XPHOZAH 30 MG, Kerendia, IBSRELA, FARXIGA, Ozempic, Wegovy, FUROSCIX.
Industry payments across NM — which companies pay providers there.
